Literature DB >> 1464419

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.

S P Cobbold1, S Qin, L Y Leong, G Martin, H Waldmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1464419     DOI： 10.1111/j.1600-065x.1992.tb01423.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  21 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

3.  Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.

Authors:  Lucienne Chatenoud; Jean-François Bach
Journal:  Rev Diabet Stud       Date:  2005-11-10

Review 4.  Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

Authors:  Lucienne Chatenoud
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 5.  Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.

Authors:  J Isaacs; A Dick
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

6.  Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.

Authors:  X K Li; A Tamura; M Fujino; L Guo; T Kakefuda; N Funeshima; S Enosawa; M Amari; S Naoe; H Amemiya; S Suzuki
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

7.  Bilateral hyphaema following diode laser for retinopathy of prematurity.

Authors:  P Rundle; F G McGinnity
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

8.  Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.

Authors:  J D Isaacs; G Hale; H Waldmann; A D Dick; R Haynes; J V Forrester; P Watson; P A Meyer
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

9.  Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells.

Authors:  J L Viney; L Dianda; S J Roberts; L Wen; C A Mallick; A C Hayday; M J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.

Authors:  J D Isaacs; N Burrows; M Wing; M T Keogan; P R Rebello; R A Watts; R J Pye; P Norris; B L Hazelman; G Hale; H Waldmann
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.